Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ACHV

Achieve Life Sciences Inc

Dec 11 • 04:00PM ET

4.24

Dollar change -0.14
Percentage change -3.20	%

Healthcare • Biotechnology • Canada • NASD

Peers: ARWR GERN IMMP SGMO ANIP AMRN ALDX ATRA AXSM CRBP

| Held by: VTI IWM VXF SURI IWO VTWO IWN IWC VTWG RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.13	Insider Own	19.75%	Shs Outstand	34.39M	Perf Week	-6.40%
Market Cap	145.81M	Forward P/E	-	EPS next Y	-1.14	Insider Trans	0.00%	Shs Float	27.60M	Perf Month	-5.15%
Income	-32.94M	PEG	-	EPS next Q	-0.34	Inst Own	48.84%	Short Float	10.36%	Perf Quarter	-2.53%
Sales	0.00M	P/S	-	EPS this Y	18.58%	Inst Trans	-6.78%	Short Ratio	26.17	Perf Half Y	-18.77%
Book/sh	0.91	P/B	4.65	EPS next Y	6.35%	ROA	-91.19%	Short Interest	2.86M	Perf Year	-22.20%
Cash/sh	1.25	P/C	3.40	EPS next 5Y	-	ROE	-186.03%	52W Range	3.03 - 5.59	Perf YTD	2.91%
Dividend Est.	-	P/FCF	-	EPS past 5Y	53.91%	ROI	-79.96%	52W High	-24.15%	Beta	1.64
Dividend TTM	-	Quick Ratio	6.78	Sales past 5Y	0.00%	Gross Margin	-	52W Low	39.93%	ATR (14)	0.21
Dividend Ex-Date	-	Current Ratio	6.78	EPS Y/Y TTM	46.27%	Oper. Margin	-	RSI (14)	39.22	Volatility	4.79% 4.56%
Employees	22	Debt/Eq	0.31	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	15.56
Option/Short	Yes / Yes	LT Debt/Eq	0.31	EPS Q/Q	-8.26%	Payout	-	Rel Volume	1.20	Prev Close	4.38
Sales Surprise	-	EPS Surprise	-32.50%	Sales Q/Q	-	Earnings	Nov 07 AMC	Avg Volume	109.22K	Price	4.24
SMA20	-3.79%	SMA50	-9.78%	SMA200	-9.22%	Trades		Volume	130,829	Change	-3.20%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy	$12
Sep-27-24	Initiated	Raymond James	Strong Buy	$20
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Dec-09-24 08:30AM	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer (GlobeNewswire)
Dec-03-24 08:30AM	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA (GlobeNewswire)
Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
08:00AM	Loading…
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)
08:00AM	Loading…
Jul-15-24 08:00AM	Milestone Pharmaceuticals Refreshes Board of Directors (GlobeNewswire)
Jul-09-24 08:00AM	Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 (GlobeNewswire)
Jul-01-24 08:00AM	Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes (GlobeNewswire)
May-29-24 08:00AM	Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes (GlobeNewswire)
May-17-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting (GlobeNewswire)
May-13-24 08:55AM	Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating (MT Newswires)
May-10-24 03:47PM	Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results (GuruFocus.com)
12:41PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:01PM	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update (GlobeNewswire)
May-06-24 11:16AM	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 (GlobeNewswire)
Apr-11-24 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference (GlobeNewswire)
Apr-01-24 03:30PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 06:24AM	Q4 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
08:53PM	Loading…
Mar-28-24 08:53PM	ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023 (InvestorPlace)
05:32PM	Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval (GuruFocus.com)
04:01PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-24 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 (GlobeNewswire)
Mar-08-24 08:35AM	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-06-24 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 08:35AM	Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024 (GlobeNewswire)
Feb-29-24 08:01AM	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission (GlobeNewswire) -9.19%
08:00AM	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Dec-15-23 08:35AM	Life Science Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire)
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire) +5.40%
Dec-12-23 01:02PM	Life Science Investor Forum Agenda Announced for December 14th, 2023 (GlobeNewswire) -42.20%
09:10AM	Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today? (InvestorPlace)
Dec-11-23 04:30PM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-11-23 10:36AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 10:01AM	Q3 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-09-23 04:00PM	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update (GlobeNewswire)
Oct-26-23 08:00AM	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 (GlobeNewswire)
Oct-03-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-11-23 08:00AM	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting (GlobeNewswire)
Sep-07-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire) -5.24%
Aug-16-23 10:30AM	ACHV: 2Q:23 Results (Zacks)
Aug-15-23 10:25PM	Q2 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:00PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Aug-01-23 08:00AM	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast (GlobeNewswire)
Jul-18-23 08:00AM	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting (GlobeNewswire)
Jul-11-23 11:23AM	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA) (GlobeNewswire)
May-25-23 09:00AM	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering (GlobeNewswire) -6.07%
07:16AM	ACHV: ORCA-3 Topline (Zacks Small Cap Research)
May-24-23 06:10AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit (Simply Wall St.)
May-23-23 02:46PM	Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial (Benzinga) -23.80%
06:00AM	Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial (GlobeNewswire)
May-17-23 08:00AM	Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank (GlobeNewswire)
May-10-23 09:08AM	ACHV: First Quarter Results (Zacks Small Cap Research) +12.71%
05:57AM	Q1 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-23 04:05PM	Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Apr-26-23 08:00AM	Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023 (GlobeNewswire)
Apr-24-23 05:27AM	ACHV: ORCA-V1 Readout (Zacks Small Cap Research)
Apr-20-23 02:22PM	Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment (Benzinga)
08:00AM	Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline (GlobeNewswire)
Apr-14-23 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference (GlobeNewswire)
Mar-30-23 08:00AM	Achieve Life Sciences Announces Refresh to Board of Directors (GlobeNewswire) +5.86%
Mar-29-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.57%
Mar-20-23 10:46PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript (Insider Monkey)
05:27AM	ACHV: 2022 Financial and Operational Results (Zacks Small Cap Research)
Mar-17-23 08:00AM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
05:48AM	Q4 2022 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 04:05PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update (GlobeNewswire)
Mar-08-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Mar-03-23 08:00AM	Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire) +7.79%
Mar-02-23 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023 (GlobeNewswire)
Feb-15-23 05:42AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) top owners are individual investors with 56% stake, while 43% is held by institutions (Simply Wall St.) -15.52%
Feb-07-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Feb-02-23 08:00AM	Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 04:30PM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
Jan-09-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.28%
Dec-29-22 06:02AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 08:00AM	Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation (GlobeNewswire)
Nov-21-22 06:01AM	ACHV: 3Q:22 Results: Target Enrollments Reached (Zacks Small Cap Research)
Nov-15-22 08:00AM	Achieve Life Sciences Announces Private Placement of $18.9 Million (GlobeNewswire) +5.45%
Nov-14-22 04:05PM	Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Nov-08-22 08:00AM	Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial (GlobeNewswire)
Oct-31-22 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022 (GlobeNewswire)
Sep-27-22 08:00AM	Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) -7.42%
Sep-07-22 08:00AM	Achieve Life Sciences Announces Participation at Fall Investor Conferences (GlobeNewswire)
Aug-15-22 06:16AM	ACHV: Autumn Enrollment Completion for ORCA-3 (Zacks Small Cap Research) +12.80%
Aug-11-22 04:05PM	Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Jul-28-22 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022 (GlobeNewswire)
Jul-01-22 04:05PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wan Jerry	Principal Accounting Officer	Apr 19 '24	Option Exercise	0.00	5,625	0	12,057	Apr 23 04:39 PM
JACOBS CINDY	President & CMO	Apr 19 '24	Option Exercise	0.00	16,250	0	34,511	Apr 23 04:35 PM
Stewart Richard Alistair	Executive Chairman	Apr 19 '24	Option Exercise	0.00	22,500	0	61,001	Apr 23 04:31 PM
Bencich John	CEO	Apr 19 '24	Option Exercise	0.00	25,000	0	101,724	Apr 23 04:26 PM
Stewart Richard Alistair	Executive Chairman	Mar 04 '24	Buy	4.58	10,000	45,850	38,501	Mar 06 04:49 PM
Bencich John	CEO	Mar 04 '24	Buy	4.58	10,000	45,850	76,724	Mar 06 04:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc

Upgrade your FINVIZ experience